The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $38.17

Today's change0.00 0.00%
Updated January 18 4:02 PM EST. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $38.17

Today's change0.00 0.00%
Updated January 18 4:02 PM EST. Delayed by at least 15 minutes.

GlaxoSmithKline PLC closed at (U.S.)$38.17.

Over the last five days, shares have gained 3.61%, but are currently unchanged over the last 52 weeks. This lagged the 23.16% return in the S&P 500.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $38.17
  • High--
  • Low--
  • Bid / Ask(U.S.) $38.19 / (U.S.) $38.21
  • YTD % change+7.61%
  • Volume5,600
  • Average volume (10-day)5,751,823
  • Average volume (1-month)5,470,665
  • Average volume (3-month)5,075,605
  • 52-week range(U.S.) $34.52 to (U.S.) $44.54
  • Beta0.98
  • Trailing P/E28.92×
  • P/E 1 year forward13.23×
  • Forward PEG1.47×
  • Indicated annual dividend(U.S.) $2.07
  • Dividend yield5.41%
  • Trailing EPS(U.S.) $1.32
Updated January 18 4:02 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue7,8437,3207,3847,586
Total other revenue--------
Total revenue7,8437,3207,3847,586
Gross profit5,4025,1905,0325,257
Total cost of revenue2,4412,1302,3522,329
Total operating expense5,9587,3205,6666,991
Selling / general / administrative2,2802,2942,3472,476
Research & development8981,0539191,017
Depreciation / amortization12111110
Interest expense (income), net operating--------
Unusual expense (income)4341,9301191,276
Other operating expenses, total-107-98-82-117
Operating income1,88501,718595
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1,711-1781,550423
Income after tax1,395-861,223317
Income tax, total316-92327106
Net income1,212-1801,046257
Total adjustments to net income--------
Net income before extra. items1,212-1801,046257
Minority interest-183-94-177-60
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,212-1801,046257
Inc. avail. to common incl. extra. items1,212-1801,046257
Diluted net income1,212-1801,046257
Dilution adjustment--0--0
Diluted weighted average shares4,9354,8774,8774,957
Diluted EPS excluding extraordinary itemsvalue per share0.25-0.040.210.05
Dividends per sharevalue per share0.190.190.190.23
Diluted normalized EPSvalue per share0.310.260.230.25